A new study published in Leukemia revealed that researchers at the Institute of Cancer Research in London have found a new genetic test that could help doctors determine which patients with multiple myeloma are at “ultra high risk” of their cancer progressing aggressively in its early stages.1 The results of the research showed that a particular genetic...Continue Reading